Sun Pharmaceutical wins U.S. approval to buy Ranbaxy
WASHINGTON (Reuters) - India's Sun Pharmaceutical Industries Ltd has won U.S. approval to buy Ranbaxy Laboratories Ltd on condition that it sell its interest in a generic antibacterial medicine, the...
Read more »